Medtronic (MDT) Tops Q1 EPS by 2c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Jefferies Raises Price Target on Medtronic (MDT) to $100 Following 1Q Report
August 26, 2016 10:42 AM EDTJefferies reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $100.00 (from $93.00), following the company's 1Q earnings report. EPS was reported $0.02 above estimates. FX was only $7mn v. the $25- $75mn guided to and the company missed consensus by about... More
Oppenheimer Raises Price Target on Medtronic (MDT) to $94 Following EPS Beat
August 26, 2016 9:44 AM EDTOppenheimer reiterated an Outperform rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $94.00 (from $90.00), following the company's 1Q earnings report. MDT reported a $0.02 EPS beat, driven by a slightly lower interest expense and tax rate.
Analyst Steven Lichtman commented,... More
UBS Reiterates Buy on Medtronic (MDT) Following 1Q Report
August 26, 2016 8:55 AM EDTUBS reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $96.00 (from $92.00), following the company's 1Q earnings report. Management reiterated F17 guidance of 5-6% top-line adjusted CC growth and EPS guidance of $4.60-4.70.
Analyst Matt Miksic commented, "Management delivered on its F1Q17 guidance of 5.0 5.5% adjusted... More
